In the evolving lands Peptide Macrocycles cape of chemical biology and molecular engineerin by AM White · 2016 · Cited by 97 — Some macrocyclic peptides such as cyclotides offer the potential for production in plants, thus reducing manufacture costs and potentially increasing. g, macrocyclic peptides have emerged as a transformative class of compounds. As someone deeply interested in the structural nuances of advanced molecular science, I have spent significant time examining the li Macrocycles and macrocyclization in anticancer drug terature to understand why this specific modality is currently capturing the attention of researchers worldwide. This macrocyclic peptide review aims to synthesize the current state of the field, focusing on structural integrity and the unique properties that make these molecules so fascinating.
Understanding the Structural Architecture
At its core, a macrocyclic peptide is defined as a peptide constrained into a ring (or multiple rings) through a covalent linkage that closes the chain. Unlike linear peptides, which are often susceptible to rapid enzym by ME Nepveu-Traversy · 2025 · Cited by 1 — To address this issue, we develop a strategy using macrocyclic peptides designed to mimic the three-dimensional structure of GPCR extracellular atic degradation, these circular structures are characterized by a circular sequence of amino acids that provides inherent stability.
From by PG Dougherty · 2017 · Cited by 205 — Macrocyclic compounds such as cyclic peptides have emerged as a new and exciting class of drug candidates for inhibition of intracellular protein-protein a structural perspective, the classification of these molecules is typically determined by their cyclization style. In my research into various peptides, I have found that they generally fall into three main c Macrocyclic Peptide Drugs From the Ground Up ategories:
* Sidechain-to-sidechain
* Head-to-sidechain
* Head-to-tail (backbone) cycles
These diverse configurations are why macrocyclic peptides are considered an attractive class of compounds for those studying molecular scaffolding. While peptides offer biocompatibility due to their similarity to proteins, as drug candidates they suffer drawbacks that include low plasma bioavailability, The ability to utilize methods to transform intact peptides into stable, templated macrocycles allows for a degree of design precision that was previously difficult to achieve with standard linear chains.
Why Macrocycles Outperform Traditional Therapeutics
One of the most compelling aspects of this field is the observation that macrocycles outperform traditional therapeutics in specific, challenging environments. A major hurdle in working with standard peptides is their vulnerability to metabolic breakdown. However, macrocyclic peptides resist degradation by stomach acid and proteases, which significantly increases their half-life and stability.
Furthermore, macrocyclic peptides occupy a unique niche between small molecules and biologics. They possess the high target affinity often associated with larger proteins but retain the structural rigidity required for membrane permeability. Recent reviews highlight that these molecules have been shown to be orally bioavailable ligands, a feature that makes them highly efficient tools in the study of complex biological interfaces.
Applications in Protein Interaction Studies
The primary utility of these molecules lies in their ability to interact with challenging surfaces. They are promising candidates of PPI regulators (protein-protein interaction regulators) because they can mimic the three-dimensional structures required to dock into specific binding pockets. Many experts argue that they are ideal drugs for targeting protein-protein interactions, particularly when dealing with "undruggable" targets that small molecules struggle to influence.
In the context of Macrocyclic Peptides in Drug Discovery, the field has moved toward high-throughput methodologies. Specifically, the use of nucleotide-encoded mass library screening (NELS) techniques has revolutionized how we identify high-affinity binders. This technological leap ensures that researchers can navigate the vast chemical space of potential macrocycles with unprecedented speed.
Personal Perspective on the Field
Having followed the progression of this technology, it is clear that we are witnessing a shift in how we approach molecular design. Macrocyclic peptides have emerged as a new and exciting class of drug candidates because they bridge the gap between simple chemistry and complex biology.
While the synthesis of these rings can be complex—often involving challen May 6, 2024 — Macrocyclic peptides fall between the sizes of small molecule drugs and large biologics. It makes them ideal drugs for targeting protein-protein interactions. ges in chemical selectivity—the rewards in by C Zhang · 2024 · Cited by 41 — Several recent comprehensive reviews have discussed macrocycle drug discovery, drug-like macrocycles highlighting reactions, cyclic peptide-based drug candidate terms of metabolic stability and target engagement are substantial. Whether you are looking at natural cyclotides or synthetic, template-constrained designs, the potential for these molecules to act as sophisticated molecular probes is immense. As the literature continues to expand, it remains a privilege to observe the maturation of this "Goldilocks" drug class, which hits the perfect balance between size, complexity, and stability.
By continuing to refine our cyclization strategies, we are undoubtedly unlocking new ways to interrogate biological systems, confirming that the future of macrocyclic peptide research is as promising as it is technically rigorous.